Neurotechnology Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Global Neurotechnology 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o up ,  t i t l e d  " N e u r o te c h n o lo g y  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  n e u r o te c h n o l o gy  m a r k e t  s i z e  r ea c h e d  U S $  11 . 4  B i l l i on  i n  2 0 23 .
Fac tors  A f fec t ing  the  Growth  o f  t he  Neuro technology  Indus t ry :
Report Advancement s  in  Neurosc ience  and  Techno logy :C on t i n u ou s  r e s e a r c h  a nd  d e v e l o pm e n t  i n  n e u r o s c i e nc e  a n d  t e c hn o l o g y  o f f e rs  
r em a r k ab l e  i n n o v a t i o n s ,  n o t a b l y  i n  t h e  d ev e l o p me n t  o f  b r a i n - co m p u t e r  i n t e r f a c es  
Highlight and ( B C I s ) ,  n e u r a l  p r o s t he t i c s ,  n e u ro s t i m u l a t i o n  d e v i ce s ,  an d  ne u r o f ee d b a ck  sy s t e m s .  T he s e  ad v a n c em e n t s  a r e  t r a n s f o rm i n g  th e  f i e l d  o f  n e u r o t ec h n o l o gy ,  e x te n d i n g  i t s  
ap p l i c a t i o ns  f a r  b e y o n d  t r a d i t i o n a l  bo u n d a r i e s .  
Description Mo r e o ve r ,  B C I s  a l l o w  d i r ec t  c o m mu n i c a t i on  p a t h w a y s  b e tw e e n  t h e  b r a i n  a n d  e x t e r na l  
de v i c e s ,  o f f e r i n g  g r o u n d b r e a k i n g  s o l u t i o n s ,  es p e c i a l l y  f o r  i n d i v i d ua l s  w i t h  p a r a l ys i s  o r  
se v e r e  m o t o r  i m p a i r m e n t s .  B e s i d e s  t h i s ,  n e u r a l  p r os t h e t i c s  a r e  a n o t he r  a re a  o f  r ap i d  
ad v a n c e me n t ,  p r o v i d i n g  re s t o r ed  f u n c t i o na l i t i e s  f o r  t h o s e  w h o  h a v e  l os t  t h em  d u e  to  
i n j u r y  o r  i l l ne s s .  B e s i d e s  t h i s ,  n eu r o s t i m u l a t i o n  d e v i c es ,  i n c l u d i n g  d e e p  b ra i n  
s t i mu l a t o r s ,  a r e  o f fe r i n g  n e w  h o pe  f o r  co n d i t i o ns  l i k e  P a r k i n so n ' s  d i s e a se  a n d  m a j o r  
de p r e s s i on ,  s i gn i f i c a n t l y  i m p r ov i n g  pa t i e n t  o u t c o me s .
Increas ing Preva lence of  Neurologica l  Disorders:
The  r i s in g  n um b er  o f  neu r o log i ca l  d i s o r de r s  su ch  a s  A l zhe im er ' s ,  P a r k in son ' s ,  
ep i l ep sy ,  an d  dep r ess io n  i s  im p ac t i ng  hea l t hca r e  sys t em s  an d  d r i v i ng  t h e  dem a nd  
f o r  adv anced  neu r o t ec hno log i ca l  s o lu t i o ns .  T hese  cond i t i ons ,  a f f ec t i ng  m i l l i on s ,  
p r es en t  subs t an t i a l  c ha l l en ges  t o  t he  a f f e c t e d  i nd i v idu a l s ,  t o  t he i r  f am i l i es ,  and  t he  
Report b r oa de r  he a l t hc a r e  i n f r as t r uc t u r e .  Th e  com p lex i t y  o f  t he se  d i s o r de r s  r equ i r es  
i nnov a t i ve  app r oach es  f o r  e f f ec t i v e  m anage m en t  and  t r e a t m e n t .  
Highlight and M or eove r ,  ne u r o t e chno logy  o f f e r s  p r om is ing  p r os pec t s  i n  t h i s  r e ga r d ,  p r ov id ing  adv an ced  t o o l s  f o r  accu r a t e  d iagn os i s ,  r ea l - t im e  m o n i t o r in g ,  a nd  e f f ec t i ve  
t r ea t m en t .  A l s o ,  va r i ous  i nnova t i ons  such  as  adv ance d  im a g ing  s ys t em s ,  
Description neu r o t he r apeu t i c  dev ic es ,  a nd  pe r s ona l i z ed  m ed ic ine  app r oac hes  a r e  t r an s f o r m ing  
t he  m a nagem en t  o f  t he se  cond i t i ons ,  o f f e r i n g  h ope  f o r  im p r oved  qu a l i t y  o f  l i f e ,  
enha nced  pa t i en t  ou t com es ,  and  even  po t e n t i a l  cu r e s .
Ris ing Investment  in  Research & Development:
The  neu r o t ech no lo gy  se c t o r  i s  expe r ienc in g  a  s ign i f i can t  i n f l u x  o f  i nves t m en t  i n  
r ese a r ch  and  dev e lopm en t  ( R& D)  f r om  pub l i c  and  p r i va t e  en t i t i es .  I n  add i t i on ,  
f i na nc ia l  bac k ing  i s  c r uc i a l  f o r  f u e l i ng  ong o ing  i nn ova t i o n  and  f ac i l i t a t i n g  t he  
t r an s i t i on  o f  g r ound b r ea k ing  r e sea r ch  f r om  labo r a t o r y  se t t i ngs  t o  p r a c t i ca l ,  r ea l -
wo r ld  app l i ca t i on s .
Moreover ,  i nves tments  a re  enab l ing  the  exp lo ra t ion  o f  new f ron t ie rs  in  
neurosc ience ,  fos te r ing  the  deve lopment  o f  cu t t i ng -edge  techno log ies  and  
the rap ies  tha t  p romise  to  t rans fo rm hea l thca re  landscapes .  These  funds  
suppo r t  t he  d iscove ry  o f  nove l  t rea tmen ts  and  d iagnos t ics  and  a id  in  the  
re f inement  and  enhancement  o f  ex i s t i ng  neuro techno log ica l  t oo ls ,  ensur ing  
they  a re  more  e f fec t ive ,  access ib le ,  and  use r - f r i end ly .
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/neu ro techno logy-marke t / reques tsamp le
Description
Report Description
Global  Neurotechnology Market  Trends:
At  p resen t ,  t he  deve lopment  o f  BCI s  i s  d r i v ing  innova t i on  in  neuro t echno logy ,  enab l i ng  d i rec t  communica t ion  be tween  
the  b ra in  and  ex te rna l  dev ices  wh ich  i s  employed  in  hea l t hca re ,  gaming ,  and  access ib i l i t y .  Moreover ,  neu ro imag ing  
techn iques  such  as  MRI ,  EEG,  and fN IRS a re  becoming more  soph is t i ca t ed ,  a l low ing  fo r  be t t e r  unders tand ing  and  
v isua l i za t ion  o f  b ra in  ac t i v i t y .  These  t echn iques  a re  c ruc ia l  i n  bo t h  c l i n i ca l  and  research  se t t i ngs .  
A long  w i t h  th i s ,  neuro techno logy  i s  em ployed  i n  hea l thca re  fo r  t he  d iagnos is ,  t rea t men t ,  and  rehab i l i t a t ion  o f  
neuro log ica l  d i sorders  such  as  Park inson 's  d isease,  ep i lepsy ,  and  s t rokes  i nc lud ing  neuros t im u la t i on  dev i ces ,  
neuromodu la t ion  t he rap ies ,  and  neuro feedback  sys tems .  Bes ides  t h is ,  t he  demand  fo r  wearab le  neu rodev i ces  f o r  
mon i t o r i ng  b ra in  ac t i v i t y  in  rea l - t ime i s  w ide ly  app l ied  in  we l lness ,  spo r t s  per fo rmance ,  and  men t a l  hea l th  t rack ing .
Look ing  fo rward ,  the  market  to  reach  US$  28 . 2  B i l l ion  by  2032 ,  exh ib i t ing  a  g rowth  rate  (CAGR)  o f  10 .54% 
dur ing  2024-2032 .
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/neuro techno l ogy-market
Product Type Insights:
• Imaging Modalit ies
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT)
o Positron Emission Tomography (PET)
• Neurostimulation
Report o Transcranial Magnetic Stimulation 
Segmentation (TMS)
o Transcranial Direct Current 
Stimulation (TDCS)
• Cranial Surface Measurement
o Electroencephalography (EEG)
o Magnetoencephalography (MEG)
• Neurological Implants
End User Insights:
• Hospitals
• Clinics
• Diagnost ic Centres
• Ambulatory Surgical  Centres
Report 
Segmentation Regional Insights:
• North America
• Europe
• Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• Al lengers Medical  Systems Ltd
• Canon Medical  Systems Corporat ion (Canon 
Inc.)
• Elekta Solut ions AB
Competitive • GE HealthCare Technologies Inc.  (General  
E lectr ic)
Landscape • Koninkl i jke Phi l ips N.V.
with Key • Natus Medical  Incorporated, Shimadzu 
Corporation
Players • Siemens Healthcare GmbH (Siemens AG)
• The Magstim Company Limited
• Tristan Technologies Inc
How has the global neurotechnology market 
performed so far, and how will it perform in the 
coming years?
What are the drivers, restraints, and opportunities 
in the global neurotechnology market?
Key What is the impact of each driver, restraint, and 
opportunity on the global neurotechnology market?
Questions 
Answered in What are the key regional markets?
the Report Which countries represent the most attractive 
neurotechnology market?
What is the breakup of the market based on the 
product type?
Which is the most attractive product type in the 
neurotechnology market?
What is the breakup of the market based on the 
end user?
Which is the most attractive end user in the 
neurotechnology market?
Key What is the competitive structure of the global 
neurotechnology market?
Questions 
Answered in Who are the key players/companies in the global neurotechnology market?
the Report
1     P r e f a c e
2  S c o p e  a n d  M e t h o d o l o g y
2 . 1  O b j e c t i v e s  o f  t h e  S t u d y
2 . 2  S t a k e h o l d e r s
2 . 3  D a t a  S o u r c e s
2 . 3 . 1  P r i m a r y  S o u r c e s
2 . 3 . 2  S e c o n d a r y  S o u r c e s
2 . 4  M a r k e t  E s t i m a t i o n
Table of 2 . 4 . 1  B o t t o m - U p  A p p r o a c h2 . 4 . 2  To p - D o w n  A p p r o a c h
2 . 5  F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4  G l o b a l  N e u r o t e c h n o l o g y  M a r k e t  -  I n t r o d u c t i o n
Contents 4 . 1  O v e r v i e w4 . 2  M a r k e t  D y n a m i c s
4 . 3  I n d u s t r y  Tr e n d s
4 . 4  C o m p e t i t i v e  I n t e l l i g e n c e
5  G l o b a l  N e u r o t e c h n o l o g y  M a r k e t  L a n d s c a p e
5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  Tr e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6  G l o b a l  N e u r o t e c h n o l o g y  M a r k e t  -  B r e a k u p  b y  P r o d u c t  Ty p e
6 . 1  I m a g i n g  M o d a l i t i e s
6 . 1 . 1  O v e r v i e w
6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  Tr e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
6 . 1 . 3 . 1  M a g n e t i c  R e s o n a n c e  I m a g i n g  ( M R I )
6 . 1 . 3 . 2  C o m p u t e d  To m o g r a p h y  ( C T )
6 . 1 . 3 . 3  P o s i t r o n  E m i s s i o n  To m o g r a p h y  ( P E T )
6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
6.2  Neurost imu la t ion
6 .2 . 1  Ov e rv i ew
6 .2 . 2  H i s to r i c a l  a nd  C urren t  Ma rke t  Trends  (2 018 -202 3 )
6 .2 . 3  Ma rke t  Segm ent a t i o n
6 .2 . 3 . 1  Tra n sc ra n i a l  Ma g ne t i c  S t i mu la t i o n  ( TMS)
6 .2 . 3 . 2  Tra n sc ra n i a l  D i rec t  Cu r ren t  S t im u l a t i o n  ( TDCS )
6 .2 . 4  Ma rke t  Fo rec a s t  ( 202 4 -20 32 )
6.3  Cran ia l  Sur face  Measurement
6 .3 . 1  Ov e rv i ew
6 .3 . 2  H i s to r i c a l  a nd  C urren t  Ma rke t  Trends  (2 018 -202 3 )
6 .3 . 3  Ma rke t  Segm ent a t i o n
Table of 6 .3 . 3 . 1  E l ec t ro enc eph a lo g ra ph y  ( EEG )6 .3 . 3 . 2  Ma gn e to enc ep ha lo g ra p hy  (MEG )
6 .3 . 4  Ma rke t  Fo rec a s t  ( 202 4 -20 32 )
6.4  Neuro log ica l  Imp lants
Contents 6 .4 . 1  Ov e rv i ew6 .4 . 2  H i s to r i c a l  a nd  C urren t  Ma rke t  Trends  (2 018 -202 3 )
6 .4 . 3  Ma rke t  Segm ent a t i o n
6 .4 . 4  Ma rke t  Fo rec a s t  ( 202 4 -20 32 )
6.5  Att ract ive  Investment  Propos i t ion  by  Product  Type
7 G loba l  Neurotechno logy  Market  -  B reakup  by  End User
7.1  Hosp i ta l s
7 .1 . 1  Ov e rv i ew
7 .1 . 2  H i s to r i c a l  a nd  C urren t  Ma rke t  Trends  (2 018 -202 3 )
7 .1 . 3  Ma rke t  Segm ent a t i o n
7 .1 . 4  Ma rke t  Fo rec a s t  ( 202 4 -20 32 )
7.2  C l in i cs
7 .2 . 1  Ov e rv i ew
7 .2 . 2  H i s to r i c a l  a nd  C urren t  Ma rke t  Trends  (2 018 -202 3 )    
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /n euro tec hno l o gy -ma rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]